5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane CAS 461432-23-5 Dapagliflozin Intermediate Factory

Takaitaccen Bayani:

Suna: 5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane

Synonyms: 4-Bromo-1-Chloro-2- (4-Ethoxybenzyl) benzene

Saukewa: 461432-23-5

Tsafta: ≥99.0% (HPLC)

Bayyanar: Fari zuwa Pael Yellow Crystalline Powder

Matsakaicin Dapagliflozin (CAS: 461432-26-8) a cikin maganin nau'in ciwon sukari na II

Kyakkyawan inganci, Samar da Kasuwanci

Inquiry: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Samar da Maƙera, Babban Tsafta, Samar da Kasuwanci
Dapagliflozin (CAS: 461432-26-8) Matsakaici masu alaƙa:
5-Bromo-2-Chlorobenzoic Acid CAS 21739-92-4
5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane CAS 461432-23-5
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS 32384-65-9

Abubuwan Sinadarai:

Sunan Sinadari 5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane
Makamantu 4-Bromo-1-Chloro-2- (4-Ethoxybenzyl) benzene;4- (5-Brom-2-Chlorbenzyl) phenyl-Ethylether;Dapagliflozin Bromo rashin tsabta
Lambar CAS 461432-23-5
Lambar CAT Saukewa: RF-PI447
Matsayin Hannun jari A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta Saukewa: C15H14BrClO
Nauyin Kwayoyin Halitta 325.63
Matsayin narkewa 41.0 zuwa 43.0 ℃
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Fari zuwa Pael Yellow Crystalline Foda
Tsarkake / Hanyar Bincike ≥99.0% (HPLC)
Ruwa (KF) ≤0.50%
Jimlar ƙazanta ≤1.0%
Matsayin Gwaji Matsayin Kasuwanci
Amfani Matsakaicin Dapagliflozin (CAS: 461432-26-8), nau'in ciwon sukari na II

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, Kwali Drum, 25kg / Drum, ko bisa ga abokin ciniki ta bukata.

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi.

Amfani:

1

FAQ:

Aikace-aikace:

4-Bromo-1-Chloro-2- (4-Ethoxybenzyl) benzene (CAS: 461432-23-5) ana amfani dashi azaman tsaka-tsaki a cikin haɗin Dapagliflozin (CAS: 461432-26-8).Dapagliflozin shine mai ƙarfi, zaɓin mai hana sodium mai dogaro da glucose cotransporter 2 (SGLT2) mai hanawa don kula da nau'in ciwon sukari na 2.Dapagliflozin wani sabon maganin ciwon sukari ne wanda Bristol-Myers Squibb da AstraZeneca suka haɓaka, wanda Hukumar Kula da Magunguna ta Turai (EMA) ta amince da shi a ranar 12 ga Nuwamba, 2012. A ranar 8 ga Janairu, 2014, Hukumar Abinci da Magunguna ta Amurka (FDA) ta amince da shi. don amfani dashi a cikin maganin nau'in ciwon sukari na II.

Ku rubuta sakonku anan ku aiko mana